Who invested in Ingenium Therapeutics?
Ingenium Therapeutics's investors include Capstone Partners.
Who invested in Ingenium Therapeutics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$4.1Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $4.1MNov 2023
- Investors
- 1
The rounds
- Nov 2023
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ingenium Therapeutics
How much has Ingenium Therapeutics raised?
Ingenium Therapeutics has raised $4.1M across 1 round since 2023.
When did Ingenium Therapeutics last raise?
Ingenium Therapeutics's most recent round was a Series A of $4.1M in Nov 2023.
What was Ingenium Therapeutics's biggest round?
Its most recent round, $4.1M in Nov 2023, is also its largest on record.
Who backed Ingenium Therapeutics first?
Ingenium Therapeutics's first round on record, in Nov 2023, was backed by Capstone Partners.
What stage is Ingenium Therapeutics at?
Ingenium Therapeutics's latest named round is a Series A, in Nov 2023.
Companies like Ingenium Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.